This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1998 Aug;85(4):1333-5.

doi: 10.1016/s0306-4522(97)00696-9.

Acute or chronic administration of okadaic acid to rats induces brain damage rather than Alzheimer-like neuropathology

A M Van Dam¹, J G Bol, R Binnekade, F L van Muiswinkel

Affiliations

PMID: 9681967
DOI: 10.1016/s0306-4522(97)00696-9

Acute or chronic administration of okadaic acid to rats induces brain damage rather than Alzheimer-like neuropathology

A M Van Dam et al. Neuroscience. 1998 Aug.

. 1998 Aug;85(4):1333-5.

doi: 10.1016/s0306-4522(97)00696-9.

Authors

A M Van Dam¹, J G Bol, R Binnekade, F L van Muiswinkel

Affiliation

¹ Research Institute Neurosciences Free University, Medical Faculty, Department of Pharmacology, Amsterdam, The Netherlands.

PMID: 9681967
DOI: 10.1016/s0306-4522(97)00696-9

No abstract available

PubMed Disclaimer

Comment in

The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease.
Arendt T, Holzer M, Brückner MK, Janke C, Gärtner U. Arendt T, et al. Neuroscience. 1998 Aug;85(4):1337-40. doi: 10.1016/s0306-4522(97)00697-0. Neuroscience. 1998. PMID: 9681968 No abstract available.

Similar articles

The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease.
Arendt T, Holzer M, Brückner MK, Janke C, Gärtner U. Arendt T, et al. Neuroscience. 1998 Aug;85(4):1337-40. doi: 10.1016/s0306-4522(97)00697-0. Neuroscience. 1998. PMID: 9681968 No abstract available.
An okadaic acid-induced model of tauopathy and cognitive deficiency.
Zhang Z, Simpkins JW. Zhang Z, et al. Brain Res. 2010 Nov 4;1359:233-46. doi: 10.1016/j.brainres.2010.08.077. Epub 2010 Aug 31. Brain Res. 2010. PMID: 20807517 Free PMC article.
Intracerebroventricular administration of okadaic acid induces hippocampal glucose uptake dysfunction and tau phosphorylation.
Broetto N, Hansen F, Brolese G, Batassini C, Lirio F, Galland F, Dos Santos JP, Dutra MF, Gonçalves CA. Broetto N, et al. Brain Res Bull. 2016 Jun;124:136-43. doi: 10.1016/j.brainresbull.2016.04.014. Epub 2016 Apr 21. Brain Res Bull. 2016. PMID: 27108544
Microcystin-LR and okadaic acid-induced cellular effects: a dualistic response.
Gehringer MM. Gehringer MM. FEBS Lett. 2004 Jan 16;557(1-3):1-8. doi: 10.1016/s0014-5793(03)01447-9. FEBS Lett. 2004. PMID: 14741332 Review.
Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors.
Fujiki H, Suganuma M. Fujiki H, et al. Prog Mol Subcell Biol. 2009;46:221-54. doi: 10.1007/978-3-540-87895-7_8. Prog Mol Subcell Biol. 2009. PMID: 19184590 Review.

See all similar articles

Cited by

Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits.
Koss DJ, Robinson L, Mietelska-Porowska A, Gasiorowska A, Sepčić K, Turk T, Jaspars M, Niewiadomska G, Scott RH, Platt B, Riedel G. Koss DJ, et al. Cell Mol Life Sci. 2015 Dec;72(23):4613-32. doi: 10.1007/s00018-015-1949-4. Epub 2015 Jun 13. Cell Mol Life Sci. 2015. PMID: 26070304 Free PMC article.
Neurotoxic and synaptic effects of okadaic acid, an inhibitor of protein phosphatases.
Tapia R, Peña F, Arias C. Tapia R, et al. Neurochem Res. 1999 Nov;24(11):1423-30. doi: 10.1023/a:1022588808260. Neurochem Res. 1999. PMID: 10555783 Review.
Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models.
He J, Kong J, Tan QR, Li XM. He J, et al. Cell Adh Migr. 2009 Jan-Mar;3(1):129-37. doi: 10.4161/cam.3.1.7401. Epub 2009 Jan 13. Cell Adh Migr. 2009. PMID: 19372744 Free PMC article. Review.
Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species.
Boban M, Babić Leko M, Miškić T, Hof PR, Šimić G. Boban M, et al. J Neurosci Methods. 2019 May 1;319:60-68. doi: 10.1016/j.jneumeth.2018.09.030. Epub 2018 Sep 29. J Neurosci Methods. 2019. PMID: 30278184 Free PMC article.
Is protein phosphatase inhibition responsible for the toxic effects of okadaic Acid in animals?
Munday R. Munday R. Toxins (Basel). 2013 Feb 4;5(2):267-85. doi: 10.3390/toxins5020267. Toxins (Basel). 2013. PMID: 23381142 Free PMC article. Review.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information